BANK1 controls CpG-induced IL-6 secretion via a p38 and MNK1/2/eIF4E translation initiation pathway

Journal of Immunology

Volumn 191, Issue 12, 2013, Pages 6110-6116

  Wu, Ying Yu ^a   Kumar, Ramesh ^a   Haque, Mohammed Shamsul ^a   Castillejo Loṕez, Casimiro ^b   Alarcón Riquelme, Marta E ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; INTERLEUKIN 10; INTERLEUKIN 6; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BANK1 GENE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; GENE; GENE EXPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RNA STABILITY; SIGNAL TRANSDUCTION; TLR9 GENE; TRANSLATION INITIATION;

EID: 84890373277     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301203     Document Type: Article

References (42)

1. Castillejo-López, C., A. M. Delgado-Vega, J. Wojcik, S. V. Kozyrev, E. Thavathiru, Y. Y. Wu, E. Sánchez, D. Pöllmann, J. R. López-Egido, S. Fineschi, et al. 2012. Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK. Ann. Rheum. Dis. 71: 136-142.
2. 3 receptor. EMBO J. 21: 83-92.
3. Kozyrev, S. V., M. Bernal-Quirós, M. E. Alarcón-Riquelme, and C. Castillejo-López. 2012. The dual effect of the lupus-associated polymorphism rs10516487 on BANK1 gene expression and protein localization. Genes Immun. 13: 129-138.
4. Troutman, T. D., W. Hu, S. Fulenchek, T. Yamazaki, T. Kurosaki, J. F. Bazan, and C. Pasare. 2012. Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt. Proc. Natl. Acad. Sci. USA 109: 273-278.
5. Christensen, S. R., M. Kashgarian, L. Alexopoulou, R. A. Flavell, S. Akira, and M. J. Shlomchik. 2005. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202: 321-331.
6. Bernasconi, N. L., N. Onai, and A. Lanzavecchia. 2003. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101: 4500-4504.
7. Sun, S., N. L. Rao, J. Venable, R. Thurmond, and L. Karlsson. 2007. TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders. Inflamm. Allergy Drug Targets 6: 223-235.
8. Neininger, A., D. Kontoyiannis, A. Kotlyarov, R. Winzen, R. Eckert, H. D. Volk, H. Holtmann, G. Kollias, and M. Gaestel. 2002. MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J. Biol. Chem. 277: 3065-3068.
9. Bollig, F., R. Winzen, M. Gaestel, S. Kostka, K. Resch, and H. Holtmann. 2003. Affinity purification of ARE-binding proteins identifies polyA-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization. Biochem. Biophys. Res. Commun. 301: 665-670.
10. Banerjee, S., K. Narayanan, T. Mizutani, and S. Makino. 2002. Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells. J. Virol. 76: 5937-5948.
11. Morley, S. J. 1997. Intracellular signalling pathways regulating initiation factor eIF4E phosphorylation during the activation of cell growth. Biochem. Soc. Trans. 25: 503-509.
12. Sonenberg, N. 2008. eIF4E, the mRNA cap-binding protein: from basic discovery to translational research. Biochem. Cell Biol. 86: 178-183.
13. Gingras, A. C., S. P. Gygi, B. Raught, R. D. Polakiewicz, R. T. Abraham, M. F. Hoekstra, R. Aebersold, and N. Sonenberg. 1999. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13: 1422-1437.
14. Richter, J. D., and N. Sonenberg. 2005. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 433: 477-480.
15. Livingstone, M., O. Larsson, R. Sukarieh, J. Pelletier, and N. Sonenberg. 2009. A chemical genetic screen for mTOR pathway inhibitors based on 4E-BP-dependent nuclear accumulation of eIF4E. Chem. Biol. 16: 1240-1249.
16. Kozyrev, S. V., A. K. Abelson, J. Wojcik, A. Zaghlool, M. V. Linga Reddy, E. Sanchez, I. Gunnarsson, E. Svenungsson, G. Sturfelt, A. Jönsen, et al. 2008. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat. Genet. 40: 211-216.
17. Rowlett, R. M., C. A. Chrestensen, M. Nyce, M. G. Harp, J. W. Pelo, F. Cominelli, P. B. Ernst, T. T. Pizarro, T. W. Sturgill, and M. T. Worthington. 2008. MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G452-G459.
18. Enslen, H., J. Raingeaud, and R. J. Davis. 1998. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273: 1741-1748.
19. Nagaleekar, V. K., G. Sabio, I. Aktan, A. Chant, I. W. Howe, T. M. Thornton, P. J. Benoit, R. J. Davis, M. Rincon, and J. E. Boyson. 2011. Translational control of NKT cell cytokine production by p38 MAPK. J. Immunol. 186: 4140-4146.
20. Foey, A. D., S. L. Parry, L. M. Williams, M. Feldmann, B. M. Foxwell, and F. M. Brennan. 1998. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: role of the p38 and p42/44 mitogen-activated protein kinases. J. Immunol. 160: 920-928.
21. Vanden Bush, T. J., and G. A. Bishop. 2008. TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation. Eur. J. Immunol. 38: 400-409.
22. Poudrier, J., D. van Essen, S. Morales-Alcelay, T. Leanderson, S. Bergthorsdottir, and D. Gray. 1998. CD40 ligand signals optimize T helper cell cytokine production: role in Th2 development and induction of germinal centers. Eur. J. Immunol. 28: 3371-3383.
23. Barr, T. A., S. Brown, G. Ryan, J. Zhao, and D. Gray. 2007. TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 37: 3040-3053.
24. Saito, E., M. Fujimoto, M. Hasegawa, K. Komura, Y. Hamaguchi, Y. Kaburagi, T. Nagaoka, K. Takehara, T. F. Tedder, and S. Sato. 2002. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J. Clin. Invest. 109: 1453-1462.
25. Haxhinasto, S. A., and G. A. Bishop. 2004. Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation. J. Biol. Chem. 279: 2575-2582.
26. Raught, B., and A. C. Gingras. 1999. eIF4E activity is regulated at multiple levels. Int. J. Biochem. Cell Biol. 31: 43-57.
27. Ronkina, N., A. Kotlyarov, O. Dittrich-Breiholz, M. Kracht, E. Hitti, K. Milarski, R. Askew, S. Marusic, L. L. Lin, M. Gaestel, and J. B. Telliez. 2007. The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol. Cell. Biol. 27: 170-181.
28. Mourey, R. J., B. L. Burnette, S. J. Brustkern, J. S. Daniels, J. L. Hirsch, W. F. Hood, M. J. Meyers, S. J. Mnich, B. S. Pierce, M. J. Saabye, et al. 2010. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral antiinflammatory efficacy in acute and chronic models of inflammation. J. Pharmacol. Exp. Ther. 333: 797-807.
29. Andersson, K., and R. Sundler. 2006. Posttranscriptional regulation of TNFα expression via eukaryotic initiation factor 4E (eIF4E) phosphorylation in mouse macrophages. Cytokine 33: 52-57.
30. Shveygert, M., C. Kaiser, S. S. Bradrick, and M. Gromeier. 2010. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction. Mol. Cell. Biol. 30: 5160-5167.
31. Aiba, Y., T. Yamazaki, T. Okada, K. Gotoh, H. Sanjo, M. Ogata, and T. Kurosaki. 2006. BANK negatively regulates Akt activation and subsequent B cell responses. Immunity 24: 259-268.
32. Barr, T. A., S. Brown, P. Mastroeni, and D. Gray. 2010. TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica. J. Immunol. 185: 2783-2789.
33. Alcocer-Varela, J., D. Aleman-Hoey, and D. Alarcon-Segovia. 1992. Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers. Lupus 1: 111-117.
34. Stuart, R. A., A. J. Littlewood, P. J. Maddison, and N. D. Hall. 1995. Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders. Clin. Exp. Rheumatol. 13: 17-22.
35. Linker-Israeli, M., R. J. Deans, D. J. Wallace, J. Prehn, T. Ozeri-Chen, and J. R. Klinenberg. 1991. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J. Immunol. 147: 117-123.
36. Barr, T. A., P. Shen, S. Brown, V. Lampropoulou, T. Roch, S. Lawrie, B. Fan, R. A. O'Connor, S. M. Anderton, A. Bar-Or, et al. 2012. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209: 1001-1010.
37. Eto, D., C. Lao, D. DiToro, B. Barnett, T. C. Escobar, R. Kageyama, I. Yusuf, and S. Crotty. 2011. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE 6: e17739.
38. Yan, Y., Y. H. Wang, and B. Diamond. 2012. IL-6 contributes to an immune tolerance checkpoint in post germinal center B cells. J. Autoimmun. 38: 1-9.
39. Karnowski, A., S. Chevrier, G. T. Belz, A. Mount, D. Emslie, K. D'Costa, D. M. Tarlinton, A. Kallies, and L. M. Corcoran. 2012. B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1. J. Exp. Med. 209: 2049-2064.
40. Cassese, G., S. Arce, A. E. Hauser, K. Lehnert, B. Moewes, M. Mostarac, G. Muehlinghaus, M. Szyska, A. Radbruch, and R. A. Manz. 2003. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171: 1684-1690.
41. Aiba, Y., M. Kameyama, T. Yamazaki, T. F. Tedder, and T. Kurosaki. 2008. Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. Blood 111: 1497-1503.
42. Bernal-Quirós, M., Y. Y. Wu, M. E. Alarcón-Riquelme, and C. Castillejo-López. 2013. BANK1 and BLK act through phospholipase Cγ2 in B-cell signaling. PLoS ONE 8: e59842.